Navigation Links
Autism Speaks announces 3 additional 2013 Weatherstone Predoctoral Fellows
Date:10/29/2013

NEW YORK, N.Y. (October 29, 2013) Autism Speaks, the world's leading autism science and advocacy organization, today announced three additional recipients to the fifth class of Weatherstone Predoctoral Fellows funded by the Stavros Niarchos Foundation. The fellowship program focuses on developing rising talent within the autism research community.

The Dennis Weatherstone Predoctoral was established in 2008 in memory of Sir Dennis Weatherstone, the former Chairman and CEO of J.P. Morgan . The program honors his family's enduring commitment to the education of promising scientists beginning careers in autism research. Fellows will work directly with mentors who are leading investigators in the autism field.

"These awards are investments in the future of autism research," says Autism Speaks Chief Science Officer Rob Ring. "Our Weatherstone fellowship program provides critical resources for building the early careers of autism researchers as they work on projects that ensure the development of more effective treatments."

The new Weatherstone Predoctoral Fellows include:

Frank Fishburn (Georgetown University) will evaluate near-infrared spectroscopy as a less-restrictive method for monitoring brain activity in children with autism spectrum disorder (ASD). Performing brain scans with traditional imaging techniques can be stressful for children with autism, as some have difficulty holding still or fear enclosed spaces. With this new tool, Mr. Fishburn will study how different areas of the brain respond while children perform mental tasks. The project will advance our understanding of how disrupted communication between brain regions may contribute to autism symptoms.

Natasha Ludwig (Georgia State University) will examine the effectiveness of nonverbal measures of social understanding as a way to reliably identify ASD in toddlers. In doing so, she seeks to help develop a more practical and accurate screening method for toddlers who show early signs of autism and/or have an older sibling on the spectrum. Such streamlined methods are critically needed as early screening for ASD becomes more common.

Bo Park (Drexel University) will investigate prenatal influences that may help explain autism's markedly higher prevalence in boys. Her research will focus on 175 pregnant mothers who already have a child on the autism spectrum. During their pregnancies, she will analyze their urine for environmental chemicals suspected of raising levels of male hormone. After delivery, she will measure hormone levels in cord blood and the baby's first stool. She will then examine associations between these measures and the children's scores on behavioral screening tests at 12 months of age.

To engender a network of collaboration, the Weatherstone Fellowship program will include group interaction among fellows and opportunities to meet with the Weatherstone family and the Stavros Niarchos Foundation. The fifth annual luncheon will take place on Monday, November 4 in New York City to honor the 2013 class of Fellows and the memory of Sir Dennis Weatherstone. Through the Weatherstone Fellowship program each of the Fellows will develop a network of promising science practitioners by sharing their knowledge and experiences with each other and future Weatherstone Fellows to continue the progression of autism research for years to come.


'/>"/>

Contact: Steffanie Marchese
steffanie.marchese@autismspeaks.org
646-385-8537
Autism Speaks
Source:Eurekalert  

Related medicine news :

1. An Early Start for Your Child with Autism
2. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
3. Researchers Find Gene Mutations That May Be a Key to Autism
4. Pregnancy Length May Influence Severity of Autism
5. Children Born to Obese Moms May Face Higher Autism Risk: Study
6. Online Tool Could Diagnose Autism Quickly, Developers Say
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. In Mice, Drug Reverses Symptoms of Condition Linked to Autism
9. Study of half siblings provides genetic clues to autism
10. Genes Associated With Autism Also Related to Schizophrenia
11. Publication Bias Casts Doubt on Value of Antidepressants for Autism
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Autism Speaks announces 3 additional 2013 Weatherstone Predoctoral Fellows
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: